# Progress Note 05 — Focused Visit (Follow-up)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Zora Neale Hurston (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ML040-SYN-TD
- Date: 1958-06-01
- Fictional facility: St. Posthumous Health Center
- Fictional author: Lorraine Abernathy-Osei, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Visit type: Focused Visit (Follow-up)

## Chief complaint

Eight-week review: blood pressure, potassium, lipids and heart failure. **S**

## History of present illness

Ms. Hurston returns eight weeks after spironolactone was added and two weeks after her sick visit for lightheadedness in the heat. She restarted chlorthalidone, spironolactone and dapagliflozin after two days, as planned; the lightheadedness has not returned since she moved her gardening to the early morning and drinks water through the day, and the energy assistance application for cooling help is in. She did not have the metabolic panel one to two weeks after starting spironolactone: the bus route to the laboratory changed, and she had no ride. Her home blood pressure average this week is 124/74, and she has no breathlessness on the stairs at school. Extra Help and the Medicare Savings Program were approved, and the SHINE counselor helped her choose a drug plan that begins next month. **S**

| Element | Detail |
|---|---|
| Home blood pressure | Average 124/74 mmHg |
| Missed test | Metabolic panel one to two weeks after spironolactone not done; no ride to the laboratory |
| Since the sick visit | Medicines restarted after two days; no further lightheadedness |
| Coverage | Extra Help and Medicare Savings Program approved; drug plan begins next month |
| KCCQ-12 | 72, from 54 |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Cardiovascular | Negative | No chest pain, palpitations or edema; breathless only on hurrying uphill |
| Neurological | Negative | No lightheadedness, headache, weakness or speech change |
| Musculoskeletal | Negative | No muscle aches on atorvastatin |
| Breast | Negative | No breast tenderness or swelling on spironolactone |

4 systems reviewed. **S**

## Current medications

- Amlodipine 5 mg oral tablet, one tablet every morning **S**
- Chlorthalidone 25 mg oral tablet, one-half tablet (12.5 mg) every morning **S**
- Dapagliflozin 10 mg oral tablet, one tablet daily; pause on days of vomiting, diarrhea or not eating or drinking **S**
- Atorvastatin 20 mg oral tablet, one tablet daily **S**
- Spironolactone 25 mg oral tablet, one-half tablet (12.5 mg) daily **S**

## Allergies

- No known allergy **S**

## Objective

BP 126/76 mmHg; pulse 72 bpm; respirations 16/min; temperature 36.6 °C; oxygen saturation 98% on room air; weight 81.8 kg; BMI 30 kg/m². All vital signs are synthetic.

Sodium: 138 mmol/L; Potassium: 4.2 mmol/L; Creatinine: 0.96 mg/dL; eGFR (CKD-EPI 1953): 65 mL/min/1.73 m²; Glucose: 95 mg/dL; Magnesium: 2 mg/dL; Total cholesterol: 152 mg/dL; LDL cholesterol: 76 mg/dL; HDL cholesterol: 53 mg/dL; Triglycerides: 115 mg/dL; ALT: 19 U/L; KCCQ-12 overall summary: 72. All results are synthetic.

## Change since baseline

- Sodium: 140 mmol/L at baseline, 138 mmol/L at this visit **S**
- Potassium: 3.9 mmol/L at baseline, 4.2 mmol/L at this visit **S**
- Creatinine: 0.88 mg/dL at baseline, 0.96 mg/dL at this visit **S**
- eGFR (CKD-EPI 1953): 72 mL/min/1.73 m² at baseline, 65 mL/min/1.73 m² at this visit **S**
- Glucose: 96 mg/dL at baseline, 95 mg/dL at this visit **S**
- Magnesium: 2 mg/dL at baseline, 2 mg/dL at this visit **S**
- Total cholesterol: 212 mg/dL (high) at baseline, 152 mg/dL at this visit **S**
- LDL cholesterol: 132 mg/dL (high) at baseline, 76 mg/dL at this visit **S**
- HDL cholesterol: 54 mg/dL at baseline, 53 mg/dL at this visit **S**
- Triglycerides: 130 mg/dL at baseline, 115 mg/dL at this visit **S**
- ALT: 18 U/L at baseline, 19 U/L at this visit **S**

## Physical examination

| System | Finding |
|---|---|
| General | Well; blood pressure 126/76, pulse 72; weight 81.8 kg |
| Orthostatic vital signs | Standing at three minutes 122/74 mmHg without symptoms |
| Neck | Jugular venous pressure not raised |
| Cardiovascular | Regular rhythm; S4 |
| Extremities | No edema |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Hypertensive heart disease** (I11.0). At goal: 126/76 in the clinic and 124/74 at home, without orthostatic drop. Potassium 4.2 mmol/L and creatinine 0.96 mg/dL on four blood pressure-lowering medicines. LDL 76 mg/dL on atorvastatin, down from 132. **S**
   - No change.
   - Laboratory tests on visit days where possible, and the county's transportation program for any separate trip.
   - Metabolic panel every three to six months.
2. **Heart failure with preserved ejection fraction** (I50.32). NYHA class I to II; KCCQ-12 72, from 54. **S**
   - Continue dapagliflozin and spironolactone; daily weights; heat plan.
3. **Low income** (Z59.6). Drug coverage with Extra Help from next month; Medicare premiums and copays now covered by the Medicare Savings Program. **S**
   - Move dapagliflozin from patient assistance to the drug plan when it begins.
4. **Food insecurity** (Z59.41). SNAP and the church food pantry; food lasts the month. **S**
   - Community health worker to check again at the seven-month visit.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Blood pressure in the clinic (seated, average of two readings, large cuff) | Every visit | Completed today | 126/76 mmHg; no orthostatic drop |
| Examination | Out-of-office blood pressure (ambulatory at diagnosis; home readings when treatment changes) | At diagnosis and with each treatment change | Completed today | Home average 124/74 mmHg |
| Examination | Weight, volume status (jugular venous pressure, edema, lungs) and NYHA class | Every visit | Completed today | 81.8 kg; jugular venous pressure not raised; no edema; NYHA I to II |
| Laboratory | Metabolic panel (sodium, potassium, creatinine and eGFR) and magnesium | One to two weeks after starting or changing a diuretic, SGLT2 inhibitor or MRA; then every three to six months | Deferred | The panel due one to two weeks after spironolactone was started was missed: the bus route to the laboratory changed and she had no ride. The first check came at the sick visit six weeks after the start: potassium 4.4 mmol/L, with creatinine 1.10 mg/dL from volume depletion in the heat, not from the potassium. No harm from the missed check is evident: no hyperkalemia at six weeks or today. Corrective action: laboratory tests on clinic visit days where possible, and rides through the county's transportation program for any separate trip |
| Laboratory | Metabolic panel (sodium, potassium, creatinine and eGFR) and magnesium | One to two weeks after starting or changing a diuretic, SGLT2 inhibitor or MRA; then every three to six months | Completed today | Sodium 138, potassium 4.2, creatinine 0.96 mg/dL (eGFR 65), magnesium 2.0 |
| Laboratory | Lipid panel | Four to twelve weeks after starting a statin; then yearly | Completed today | Ten weeks on atorvastatin: LDL 76 mg/dL, total cholesterol 152, HDL 53, triglycerides 115; ALT 19 U/L |
| Survey | KCCQ-12 heart failure health status | At diagnosis, then every three to six months | Completed today | 72, from 54 at diagnosis |
| Imaging | ECG and echocardiogram | At diagnosis; repeat only with unexplained clinical change | Not indicated | Improving; no unexplained change |
| Medication safety | SGLT2 inhibitor and MRA: volume depletion, potassium and sick-day rules | Every visit | Completed today | Orthostatic episode in the heat managed by the sick-day rules; no recurrence; potassium in range |
| Self-management | Self-care: daily weights, less salt, sick-day rules and the BE FAST stroke signs | Every visit | Completed today | Daily weights; heat plan; BE FAST reviewed |
| Medication safety | Medicine costs and coverage (generics, 90-day fills, patient assistance, Extra Help, Medicare Savings Program) | Every visit | Completed today | Extra Help and Medicare Savings Program approved; drug plan begins next month |
| Self-management | Food access | Every visit | Completed today | Food lasts the month with SNAP and the pantry |

## Goal progress

- Blood pressure below 130/80 mmHg in the clinic and at home within six months. Outcome by 1958-06-01: 126/76 in the clinic; home average 124/74. **S**
- Breathlessness only on heavy exertion and a KCCQ-12 score at least 15 points higher within six months. In progress; target 1958-10-19. **S**
- Every medicine affordable: generic 90-day fills, patient assistance until drug coverage begins, Extra Help and the Medicare Savings Program. Outcome by 1958-06-01: Extra Help and the Medicare Savings Program approved; enrolled in a drug plan; dapagliflozin by patient assistance until then. **S**
- Enough food through the month. Outcome by 1958-06-01: SNAP approved and the food pantry at her church; food lasts the month. **S**
- Know the BE FAST signs of stroke and call 911 at once if any appear. Outcome by 1958-04-06: She teaches back the signs and keeps the card by the telephone. **S**

## Guideline basis

- 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults (2025), American Heart Association and American College of Cardiology (Circulation 2025;152(11):e114-e218)
- 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure (2022), American Heart Association, American College of Cardiology, and Heart Failure Society of America (Circulation 2022;145(18):e895-e1032)
- CMID: Clinical Monitoring Intelligence Database, hypertension and heart failure monographs (2026), Aether Forge
- Signs and Symptoms of Stroke (2026), Centers for Disease Control and Prevention
- Help with drug costs (Extra Help) (2026), Centers for Medicare & Medicaid Services (Medicare.gov)
- Medicare Savings Programs (2026), Centers for Medicare & Medicaid Services (Medicare.gov)
- Low Income Home Energy Assistance Program (LIHEAP) (2026), U.S. Department of Health and Human Services, Administration for Children and Families

## Follow-up

- Annual wellness visit in about three months. Heart failure and blood pressure review in about four months with a metabolic panel and the KCCQ-12. Call for lightheadedness or a weight change beyond the plan; call 911 for any BE FAST sign. **S**
- Next scheduled visit 1958-09-14: subsequent annual wellness visit. **S**
